Global Lyme Disease Testing Market 2024 by Company, Regions, Type and Application, Forecast to 2030
According to our (Global Info Research) latest study, the global Lyme Disease Testing market size was valued at USD 206.3 million in 2023 and is forecast to a readjusted size of USD 316.6 million by 2030 with a CAGR of 6.3% during review period.
Lyme disease is caused by the bacterium Borrelia burgdorferi and rarely, Borrelia mayonii. It is transmitted to humans through the bite of infected blacklegged ticks. Typical symptoms include fever, headache, fatigue, and a characteristic skin rash called erythema migrans. Lyme disease is usually diagnosed by serology. RIPL uses a modified 2-tier testing approach. The initial screening test is a combined IgG and IgM ELISA that detects antibodies against 2 Borrelia burgdorferi antigens – VlsE1 and pepC10.
Global key players of Lyme Disease Testing include Quidel Corporation, Roche Holding AG and Fujirebio(H.U. Group Holdings), etc. Global top three manufacturers hold a share about 25%. North America is the largest market of Lyme Disease Testing, with a share over 60%, followed by Asia-Pacific and Europe.
The Global Info Research report includes an overview of the development of the Lyme Disease Testing industry chain, the market status of Hospital and Testing Agency (ELISA, Western Blotting), Personal (ELISA, Western Blotting), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Lyme Disease Testing.
Regionally, the report analyzes the Lyme Disease Testing markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Lyme Disease Testing market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Lyme Disease Testing market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Lyme Disease Testing industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., ELISA, Western Blotting).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Lyme Disease Testing market.
Regional Analysis: The report involves examining the Lyme Disease Testing market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Lyme Disease Testing market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Lyme Disease Testing:
Company Analysis: Report covers individual Lyme Disease Testing players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Lyme Disease Testing This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Hospital and Testing Agency, Personal).
Technology Analysis: Report covers specific technologies relevant to Lyme Disease Testing. It assesses the current state, advancements, and potential future developments in Lyme Disease Testing areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Lyme Disease Testing market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Lyme Disease Testing market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
Chapter 1, to describe Lyme Disease Testing product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Lyme Disease Testing, with revenue, gross margin and global market share of Lyme Disease Testing from 2019 to 2024.
Chapter 3, the Lyme Disease Testing competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Lyme Disease Testing market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Lyme Disease Testing.
Chapter 13, to describe Lyme Disease Testing research findings and conclusion.
Lyme disease is caused by the bacterium Borrelia burgdorferi and rarely, Borrelia mayonii. It is transmitted to humans through the bite of infected blacklegged ticks. Typical symptoms include fever, headache, fatigue, and a characteristic skin rash called erythema migrans. Lyme disease is usually diagnosed by serology. RIPL uses a modified 2-tier testing approach. The initial screening test is a combined IgG and IgM ELISA that detects antibodies against 2 Borrelia burgdorferi antigens – VlsE1 and pepC10.
Global key players of Lyme Disease Testing include Quidel Corporation, Roche Holding AG and Fujirebio(H.U. Group Holdings), etc. Global top three manufacturers hold a share about 25%. North America is the largest market of Lyme Disease Testing, with a share over 60%, followed by Asia-Pacific and Europe.
The Global Info Research report includes an overview of the development of the Lyme Disease Testing industry chain, the market status of Hospital and Testing Agency (ELISA, Western Blotting), Personal (ELISA, Western Blotting), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Lyme Disease Testing.
Regionally, the report analyzes the Lyme Disease Testing markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Lyme Disease Testing market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Lyme Disease Testing market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Lyme Disease Testing industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., ELISA, Western Blotting).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Lyme Disease Testing market.
Regional Analysis: The report involves examining the Lyme Disease Testing market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Lyme Disease Testing market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Lyme Disease Testing:
Company Analysis: Report covers individual Lyme Disease Testing players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Lyme Disease Testing This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Hospital and Testing Agency, Personal).
Technology Analysis: Report covers specific technologies relevant to Lyme Disease Testing. It assesses the current state, advancements, and potential future developments in Lyme Disease Testing areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Lyme Disease Testing market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Lyme Disease Testing market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
- ELISA
- Western Blotting
- PCR
- Others
- Hospital and Testing Agency
- Personal
- Quidel Corporation
- Roche Holding AG
- Fujirebio(H.U. Group Holdings)
- ZEUS Scientific
- IGeneX
- Thermo Fisher Scientific
- Everlywell
- Oxford Immunotec Global PLC(PerkinElmer)
- BioMerieux
- Bio-Rad Laboratories
- T2 Biosystems
- North America (United States, Canada, and Mexico)
- Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
- South America (Brazil, Argentina and Rest of South America)
- Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
Chapter 1, to describe Lyme Disease Testing product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Lyme Disease Testing, with revenue, gross margin and global market share of Lyme Disease Testing from 2019 to 2024.
Chapter 3, the Lyme Disease Testing competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Lyme Disease Testing market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Lyme Disease Testing.
Chapter 13, to describe Lyme Disease Testing research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope of Lyme Disease Testing
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Lyme Disease Testing by Type
1.3.1 Overview: Global Lyme Disease Testing Market Size by Type: 2019 Versus 2023 Versus 2030
1.3.2 Global Lyme Disease Testing Consumption Value Market Share by Type in 2023
1.3.3 ELISA
1.3.4 Western Blotting
1.3.5 PCR
1.3.6 Others
1.4 Global Lyme Disease Testing Market by Application
1.4.1 Overview: Global Lyme Disease Testing Market Size by Application: 2019 Versus 2023 Versus 2030
1.4.2 Hospital and Testing Agency
1.4.3 Personal
1.5 Global Lyme Disease Testing Market Size & Forecast
1.6 Global Lyme Disease Testing Market Size and Forecast by Region
1.6.1 Global Lyme Disease Testing Market Size by Region: 2019 VS 2023 VS 2030
1.6.2 Global Lyme Disease Testing Market Size by Region, (2019-2030)
1.6.3 North America Lyme Disease Testing Market Size and Prospect (2019-2030)
1.6.4 Europe Lyme Disease Testing Market Size and Prospect (2019-2030)
1.6.5 Asia-Pacific Lyme Disease Testing Market Size and Prospect (2019-2030)
1.6.6 South America Lyme Disease Testing Market Size and Prospect (2019-2030)
1.6.7 Middle East and Africa Lyme Disease Testing Market Size and Prospect (2019-2030)
2 COMPANY PROFILES
2.1 Quidel Corporation
2.1.1 Quidel Corporation Details
2.1.2 Quidel Corporation Major Business
2.1.3 Quidel Corporation Lyme Disease Testing Product and Solutions
2.1.4 Quidel Corporation Lyme Disease Testing Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Quidel Corporation Recent Developments and Future Plans
2.2 Roche Holding AG
2.2.1 Roche Holding AG Details
2.2.2 Roche Holding AG Major Business
2.2.3 Roche Holding AG Lyme Disease Testing Product and Solutions
2.2.4 Roche Holding AG Lyme Disease Testing Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Roche Holding AG Recent Developments and Future Plans
2.3 Fujirebio(H.U. Group Holdings)
2.3.1 Fujirebio(H.U. Group Holdings) Details
2.3.2 Fujirebio(H.U. Group Holdings) Major Business
2.3.3 Fujirebio(H.U. Group Holdings) Lyme Disease Testing Product and Solutions
2.3.4 Fujirebio(H.U. Group Holdings) Lyme Disease Testing Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Fujirebio(H.U. Group Holdings) Recent Developments and Future Plans
2.4 ZEUS Scientific
2.4.1 ZEUS Scientific Details
2.4.2 ZEUS Scientific Major Business
2.4.3 ZEUS Scientific Lyme Disease Testing Product and Solutions
2.4.4 ZEUS Scientific Lyme Disease Testing Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 ZEUS Scientific Recent Developments and Future Plans
2.5 IGeneX
2.5.1 IGeneX Details
2.5.2 IGeneX Major Business
2.5.3 IGeneX Lyme Disease Testing Product and Solutions
2.5.4 IGeneX Lyme Disease Testing Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 IGeneX Recent Developments and Future Plans
2.6 Thermo Fisher Scientific
2.6.1 Thermo Fisher Scientific Details
2.6.2 Thermo Fisher Scientific Major Business
2.6.3 Thermo Fisher Scientific Lyme Disease Testing Product and Solutions
2.6.4 Thermo Fisher Scientific Lyme Disease Testing Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Thermo Fisher Scientific Recent Developments and Future Plans
2.7 Everlywell
2.7.1 Everlywell Details
2.7.2 Everlywell Major Business
2.7.3 Everlywell Lyme Disease Testing Product and Solutions
2.7.4 Everlywell Lyme Disease Testing Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 Everlywell Recent Developments and Future Plans
2.8 Oxford Immunotec Global PLC(PerkinElmer)
2.8.1 Oxford Immunotec Global PLC(PerkinElmer) Details
2.8.2 Oxford Immunotec Global PLC(PerkinElmer) Major Business
2.8.3 Oxford Immunotec Global PLC(PerkinElmer) Lyme Disease Testing Product and Solutions
2.8.4 Oxford Immunotec Global PLC(PerkinElmer) Lyme Disease Testing Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 Oxford Immunotec Global PLC(PerkinElmer) Recent Developments and Future Plans
2.9 BioMerieux
2.9.1 BioMerieux Details
2.9.2 BioMerieux Major Business
2.9.3 BioMerieux Lyme Disease Testing Product and Solutions
2.9.4 BioMerieux Lyme Disease Testing Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 BioMerieux Recent Developments and Future Plans
2.10 Bio-Rad Laboratories
2.10.1 Bio-Rad Laboratories Details
2.10.2 Bio-Rad Laboratories Major Business
2.10.3 Bio-Rad Laboratories Lyme Disease Testing Product and Solutions
2.10.4 Bio-Rad Laboratories Lyme Disease Testing Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 Bio-Rad Laboratories Recent Developments and Future Plans
2.11 T2 Biosystems
2.11.1 T2 Biosystems Details
2.11.2 T2 Biosystems Major Business
2.11.3 T2 Biosystems Lyme Disease Testing Product and Solutions
2.11.4 T2 Biosystems Lyme Disease Testing Revenue, Gross Margin and Market Share (2019-2024)
2.11.5 T2 Biosystems Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Lyme Disease Testing Revenue and Share by Players (2019-2024)
3.2 Market Share Analysis (2023)
3.2.1 Market Share of Lyme Disease Testing by Company Revenue
3.2.2 Top 3 Lyme Disease Testing Players Market Share in 2023
3.2.3 Top 6 Lyme Disease Testing Players Market Share in 2023
3.3 Lyme Disease Testing Market: Overall Company Footprint Analysis
3.3.1 Lyme Disease Testing Market: Region Footprint
3.3.2 Lyme Disease Testing Market: Company Product Type Footprint
3.3.3 Lyme Disease Testing Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Lyme Disease Testing Consumption Value and Market Share by Type (2019-2024)
4.2 Global Lyme Disease Testing Market Forecast by Type (2025-2030)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Lyme Disease Testing Consumption Value Market Share by Application (2019-2024)
5.2 Global Lyme Disease Testing Market Forecast by Application (2025-2030)
6 NORTH AMERICA
6.1 North America Lyme Disease Testing Consumption Value by Type (2019-2030)
6.2 North America Lyme Disease Testing Consumption Value by Application (2019-2030)
6.3 North America Lyme Disease Testing Market Size by Country
6.3.1 North America Lyme Disease Testing Consumption Value by Country (2019-2030)
6.3.2 United States Lyme Disease Testing Market Size and Forecast (2019-2030)
6.3.3 Canada Lyme Disease Testing Market Size and Forecast (2019-2030)
6.3.4 Mexico Lyme Disease Testing Market Size and Forecast (2019-2030)
7 EUROPE
7.1 Europe Lyme Disease Testing Consumption Value by Type (2019-2030)
7.2 Europe Lyme Disease Testing Consumption Value by Application (2019-2030)
7.3 Europe Lyme Disease Testing Market Size by Country
7.3.1 Europe Lyme Disease Testing Consumption Value by Country (2019-2030)
7.3.2 Germany Lyme Disease Testing Market Size and Forecast (2019-2030)
7.3.3 France Lyme Disease Testing Market Size and Forecast (2019-2030)
7.3.4 United Kingdom Lyme Disease Testing Market Size and Forecast (2019-2030)
7.3.5 Russia Lyme Disease Testing Market Size and Forecast (2019-2030)
7.3.6 Italy Lyme Disease Testing Market Size and Forecast (2019-2030)
8 ASIA-PACIFIC
8.1 Asia-Pacific Lyme Disease Testing Consumption Value by Type (2019-2030)
8.2 Asia-Pacific Lyme Disease Testing Consumption Value by Application (2019-2030)
8.3 Asia-Pacific Lyme Disease Testing Market Size by Region
8.3.1 Asia-Pacific Lyme Disease Testing Consumption Value by Region (2019-2030)
8.3.2 China Lyme Disease Testing Market Size and Forecast (2019-2030)
8.3.3 Japan Lyme Disease Testing Market Size and Forecast (2019-2030)
8.3.4 South Korea Lyme Disease Testing Market Size and Forecast (2019-2030)
8.3.5 India Lyme Disease Testing Market Size and Forecast (2019-2030)
8.3.6 Southeast Asia Lyme Disease Testing Market Size and Forecast (2019-2030)
8.3.7 Australia Lyme Disease Testing Market Size and Forecast (2019-2030)
9 SOUTH AMERICA
9.1 South America Lyme Disease Testing Consumption Value by Type (2019-2030)
9.2 South America Lyme Disease Testing Consumption Value by Application (2019-2030)
9.3 South America Lyme Disease Testing Market Size by Country
9.3.1 South America Lyme Disease Testing Consumption Value by Country (2019-2030)
9.3.2 Brazil Lyme Disease Testing Market Size and Forecast (2019-2030)
9.3.3 Argentina Lyme Disease Testing Market Size and Forecast (2019-2030)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Lyme Disease Testing Consumption Value by Type (2019-2030)
10.2 Middle East & Africa Lyme Disease Testing Consumption Value by Application (2019-2030)
10.3 Middle East & Africa Lyme Disease Testing Market Size by Country
10.3.1 Middle East & Africa Lyme Disease Testing Consumption Value by Country (2019-2030)
10.3.2 Turkey Lyme Disease Testing Market Size and Forecast (2019-2030)
10.3.3 Saudi Arabia Lyme Disease Testing Market Size and Forecast (2019-2030)
10.3.4 UAE Lyme Disease Testing Market Size and Forecast (2019-2030)
11 MARKET DYNAMICS
11.1 Lyme Disease Testing Market Drivers
11.2 Lyme Disease Testing Market Restraints
11.3 Lyme Disease Testing Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 Lyme Disease Testing Industry Chain
12.2 Lyme Disease Testing Upstream Analysis
12.3 Lyme Disease Testing Midstream Analysis
12.4 Lyme Disease Testing Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
1.1 Product Overview and Scope of Lyme Disease Testing
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Lyme Disease Testing by Type
1.3.1 Overview: Global Lyme Disease Testing Market Size by Type: 2019 Versus 2023 Versus 2030
1.3.2 Global Lyme Disease Testing Consumption Value Market Share by Type in 2023
1.3.3 ELISA
1.3.4 Western Blotting
1.3.5 PCR
1.3.6 Others
1.4 Global Lyme Disease Testing Market by Application
1.4.1 Overview: Global Lyme Disease Testing Market Size by Application: 2019 Versus 2023 Versus 2030
1.4.2 Hospital and Testing Agency
1.4.3 Personal
1.5 Global Lyme Disease Testing Market Size & Forecast
1.6 Global Lyme Disease Testing Market Size and Forecast by Region
1.6.1 Global Lyme Disease Testing Market Size by Region: 2019 VS 2023 VS 2030
1.6.2 Global Lyme Disease Testing Market Size by Region, (2019-2030)
1.6.3 North America Lyme Disease Testing Market Size and Prospect (2019-2030)
1.6.4 Europe Lyme Disease Testing Market Size and Prospect (2019-2030)
1.6.5 Asia-Pacific Lyme Disease Testing Market Size and Prospect (2019-2030)
1.6.6 South America Lyme Disease Testing Market Size and Prospect (2019-2030)
1.6.7 Middle East and Africa Lyme Disease Testing Market Size and Prospect (2019-2030)
2 COMPANY PROFILES
2.1 Quidel Corporation
2.1.1 Quidel Corporation Details
2.1.2 Quidel Corporation Major Business
2.1.3 Quidel Corporation Lyme Disease Testing Product and Solutions
2.1.4 Quidel Corporation Lyme Disease Testing Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Quidel Corporation Recent Developments and Future Plans
2.2 Roche Holding AG
2.2.1 Roche Holding AG Details
2.2.2 Roche Holding AG Major Business
2.2.3 Roche Holding AG Lyme Disease Testing Product and Solutions
2.2.4 Roche Holding AG Lyme Disease Testing Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Roche Holding AG Recent Developments and Future Plans
2.3 Fujirebio(H.U. Group Holdings)
2.3.1 Fujirebio(H.U. Group Holdings) Details
2.3.2 Fujirebio(H.U. Group Holdings) Major Business
2.3.3 Fujirebio(H.U. Group Holdings) Lyme Disease Testing Product and Solutions
2.3.4 Fujirebio(H.U. Group Holdings) Lyme Disease Testing Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Fujirebio(H.U. Group Holdings) Recent Developments and Future Plans
2.4 ZEUS Scientific
2.4.1 ZEUS Scientific Details
2.4.2 ZEUS Scientific Major Business
2.4.3 ZEUS Scientific Lyme Disease Testing Product and Solutions
2.4.4 ZEUS Scientific Lyme Disease Testing Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 ZEUS Scientific Recent Developments and Future Plans
2.5 IGeneX
2.5.1 IGeneX Details
2.5.2 IGeneX Major Business
2.5.3 IGeneX Lyme Disease Testing Product and Solutions
2.5.4 IGeneX Lyme Disease Testing Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 IGeneX Recent Developments and Future Plans
2.6 Thermo Fisher Scientific
2.6.1 Thermo Fisher Scientific Details
2.6.2 Thermo Fisher Scientific Major Business
2.6.3 Thermo Fisher Scientific Lyme Disease Testing Product and Solutions
2.6.4 Thermo Fisher Scientific Lyme Disease Testing Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Thermo Fisher Scientific Recent Developments and Future Plans
2.7 Everlywell
2.7.1 Everlywell Details
2.7.2 Everlywell Major Business
2.7.3 Everlywell Lyme Disease Testing Product and Solutions
2.7.4 Everlywell Lyme Disease Testing Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 Everlywell Recent Developments and Future Plans
2.8 Oxford Immunotec Global PLC(PerkinElmer)
2.8.1 Oxford Immunotec Global PLC(PerkinElmer) Details
2.8.2 Oxford Immunotec Global PLC(PerkinElmer) Major Business
2.8.3 Oxford Immunotec Global PLC(PerkinElmer) Lyme Disease Testing Product and Solutions
2.8.4 Oxford Immunotec Global PLC(PerkinElmer) Lyme Disease Testing Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 Oxford Immunotec Global PLC(PerkinElmer) Recent Developments and Future Plans
2.9 BioMerieux
2.9.1 BioMerieux Details
2.9.2 BioMerieux Major Business
2.9.3 BioMerieux Lyme Disease Testing Product and Solutions
2.9.4 BioMerieux Lyme Disease Testing Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 BioMerieux Recent Developments and Future Plans
2.10 Bio-Rad Laboratories
2.10.1 Bio-Rad Laboratories Details
2.10.2 Bio-Rad Laboratories Major Business
2.10.3 Bio-Rad Laboratories Lyme Disease Testing Product and Solutions
2.10.4 Bio-Rad Laboratories Lyme Disease Testing Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 Bio-Rad Laboratories Recent Developments and Future Plans
2.11 T2 Biosystems
2.11.1 T2 Biosystems Details
2.11.2 T2 Biosystems Major Business
2.11.3 T2 Biosystems Lyme Disease Testing Product and Solutions
2.11.4 T2 Biosystems Lyme Disease Testing Revenue, Gross Margin and Market Share (2019-2024)
2.11.5 T2 Biosystems Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Lyme Disease Testing Revenue and Share by Players (2019-2024)
3.2 Market Share Analysis (2023)
3.2.1 Market Share of Lyme Disease Testing by Company Revenue
3.2.2 Top 3 Lyme Disease Testing Players Market Share in 2023
3.2.3 Top 6 Lyme Disease Testing Players Market Share in 2023
3.3 Lyme Disease Testing Market: Overall Company Footprint Analysis
3.3.1 Lyme Disease Testing Market: Region Footprint
3.3.2 Lyme Disease Testing Market: Company Product Type Footprint
3.3.3 Lyme Disease Testing Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Lyme Disease Testing Consumption Value and Market Share by Type (2019-2024)
4.2 Global Lyme Disease Testing Market Forecast by Type (2025-2030)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Lyme Disease Testing Consumption Value Market Share by Application (2019-2024)
5.2 Global Lyme Disease Testing Market Forecast by Application (2025-2030)
6 NORTH AMERICA
6.1 North America Lyme Disease Testing Consumption Value by Type (2019-2030)
6.2 North America Lyme Disease Testing Consumption Value by Application (2019-2030)
6.3 North America Lyme Disease Testing Market Size by Country
6.3.1 North America Lyme Disease Testing Consumption Value by Country (2019-2030)
6.3.2 United States Lyme Disease Testing Market Size and Forecast (2019-2030)
6.3.3 Canada Lyme Disease Testing Market Size and Forecast (2019-2030)
6.3.4 Mexico Lyme Disease Testing Market Size and Forecast (2019-2030)
7 EUROPE
7.1 Europe Lyme Disease Testing Consumption Value by Type (2019-2030)
7.2 Europe Lyme Disease Testing Consumption Value by Application (2019-2030)
7.3 Europe Lyme Disease Testing Market Size by Country
7.3.1 Europe Lyme Disease Testing Consumption Value by Country (2019-2030)
7.3.2 Germany Lyme Disease Testing Market Size and Forecast (2019-2030)
7.3.3 France Lyme Disease Testing Market Size and Forecast (2019-2030)
7.3.4 United Kingdom Lyme Disease Testing Market Size and Forecast (2019-2030)
7.3.5 Russia Lyme Disease Testing Market Size and Forecast (2019-2030)
7.3.6 Italy Lyme Disease Testing Market Size and Forecast (2019-2030)
8 ASIA-PACIFIC
8.1 Asia-Pacific Lyme Disease Testing Consumption Value by Type (2019-2030)
8.2 Asia-Pacific Lyme Disease Testing Consumption Value by Application (2019-2030)
8.3 Asia-Pacific Lyme Disease Testing Market Size by Region
8.3.1 Asia-Pacific Lyme Disease Testing Consumption Value by Region (2019-2030)
8.3.2 China Lyme Disease Testing Market Size and Forecast (2019-2030)
8.3.3 Japan Lyme Disease Testing Market Size and Forecast (2019-2030)
8.3.4 South Korea Lyme Disease Testing Market Size and Forecast (2019-2030)
8.3.5 India Lyme Disease Testing Market Size and Forecast (2019-2030)
8.3.6 Southeast Asia Lyme Disease Testing Market Size and Forecast (2019-2030)
8.3.7 Australia Lyme Disease Testing Market Size and Forecast (2019-2030)
9 SOUTH AMERICA
9.1 South America Lyme Disease Testing Consumption Value by Type (2019-2030)
9.2 South America Lyme Disease Testing Consumption Value by Application (2019-2030)
9.3 South America Lyme Disease Testing Market Size by Country
9.3.1 South America Lyme Disease Testing Consumption Value by Country (2019-2030)
9.3.2 Brazil Lyme Disease Testing Market Size and Forecast (2019-2030)
9.3.3 Argentina Lyme Disease Testing Market Size and Forecast (2019-2030)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Lyme Disease Testing Consumption Value by Type (2019-2030)
10.2 Middle East & Africa Lyme Disease Testing Consumption Value by Application (2019-2030)
10.3 Middle East & Africa Lyme Disease Testing Market Size by Country
10.3.1 Middle East & Africa Lyme Disease Testing Consumption Value by Country (2019-2030)
10.3.2 Turkey Lyme Disease Testing Market Size and Forecast (2019-2030)
10.3.3 Saudi Arabia Lyme Disease Testing Market Size and Forecast (2019-2030)
10.3.4 UAE Lyme Disease Testing Market Size and Forecast (2019-2030)
11 MARKET DYNAMICS
11.1 Lyme Disease Testing Market Drivers
11.2 Lyme Disease Testing Market Restraints
11.3 Lyme Disease Testing Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 Lyme Disease Testing Industry Chain
12.2 Lyme Disease Testing Upstream Analysis
12.3 Lyme Disease Testing Midstream Analysis
12.4 Lyme Disease Testing Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
LIST OF TABLES
Table 1. Global Lyme Disease Testing Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Lyme Disease Testing Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Global Lyme Disease Testing Consumption Value by Region (2019-2024) & (USD Million)
Table 4. Global Lyme Disease Testing Consumption Value by Region (2025-2030) & (USD Million)
Table 5. Quidel Corporation Company Information, Head Office, and Major Competitors
Table 6. Quidel Corporation Major Business
Table 7. Quidel Corporation Lyme Disease Testing Product and Solutions
Table 8. Quidel Corporation Lyme Disease Testing Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 9. Quidel Corporation Recent Developments and Future Plans
Table 10. Roche Holding AG Company Information, Head Office, and Major Competitors
Table 11. Roche Holding AG Major Business
Table 12. Roche Holding AG Lyme Disease Testing Product and Solutions
Table 13. Roche Holding AG Lyme Disease Testing Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 14. Roche Holding AG Recent Developments and Future Plans
Table 15. Fujirebio(H.U. Group Holdings) Company Information, Head Office, and Major Competitors
Table 16. Fujirebio(H.U. Group Holdings) Major Business
Table 17. Fujirebio(H.U. Group Holdings) Lyme Disease Testing Product and Solutions
Table 18. Fujirebio(H.U. Group Holdings) Lyme Disease Testing Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 19. Fujirebio(H.U. Group Holdings) Recent Developments and Future Plans
Table 20. ZEUS Scientific Company Information, Head Office, and Major Competitors
Table 21. ZEUS Scientific Major Business
Table 22. ZEUS Scientific Lyme Disease Testing Product and Solutions
Table 23. ZEUS Scientific Lyme Disease Testing Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 24. ZEUS Scientific Recent Developments and Future Plans
Table 25. IGeneX Company Information, Head Office, and Major Competitors
Table 26. IGeneX Major Business
Table 27. IGeneX Lyme Disease Testing Product and Solutions
Table 28. IGeneX Lyme Disease Testing Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 29. IGeneX Recent Developments and Future Plans
Table 30. Thermo Fisher Scientific Company Information, Head Office, and Major Competitors
Table 31. Thermo Fisher Scientific Major Business
Table 32. Thermo Fisher Scientific Lyme Disease Testing Product and Solutions
Table 33. Thermo Fisher Scientific Lyme Disease Testing Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 34. Thermo Fisher Scientific Recent Developments and Future Plans
Table 35. Everlywell Company Information, Head Office, and Major Competitors
Table 36. Everlywell Major Business
Table 37. Everlywell Lyme Disease Testing Product and Solutions
Table 38. Everlywell Lyme Disease Testing Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 39. Everlywell Recent Developments and Future Plans
Table 40. Oxford Immunotec Global PLC(PerkinElmer) Company Information, Head Office, and Major Competitors
Table 41. Oxford Immunotec Global PLC(PerkinElmer) Major Business
Table 42. Oxford Immunotec Global PLC(PerkinElmer) Lyme Disease Testing Product and Solutions
Table 43. Oxford Immunotec Global PLC(PerkinElmer) Lyme Disease Testing Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 44. Oxford Immunotec Global PLC(PerkinElmer) Recent Developments and Future Plans
Table 45. BioMerieux Company Information, Head Office, and Major Competitors
Table 46. BioMerieux Major Business
Table 47. BioMerieux Lyme Disease Testing Product and Solutions
Table 48. BioMerieux Lyme Disease Testing Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 49. BioMerieux Recent Developments and Future Plans
Table 50. Bio-Rad Laboratories Company Information, Head Office, and Major Competitors
Table 51. Bio-Rad Laboratories Major Business
Table 52. Bio-Rad Laboratories Lyme Disease Testing Product and Solutions
Table 53. Bio-Rad Laboratories Lyme Disease Testing Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 54. Bio-Rad Laboratories Recent Developments and Future Plans
Table 55. T2 Biosystems Company Information, Head Office, and Major Competitors
Table 56. T2 Biosystems Major Business
Table 57. T2 Biosystems Lyme Disease Testing Product and Solutions
Table 58. T2 Biosystems Lyme Disease Testing Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 59. T2 Biosystems Recent Developments and Future Plans
Table 60. Global Lyme Disease Testing Revenue (USD Million) by Players (2019-2024)
Table 61. Global Lyme Disease Testing Revenue Share by Players (2019-2024)
Table 62. Breakdown of Lyme Disease Testing by Company Type (Tier 1, Tier 2, and Tier 3)
Table 63. Market Position of Players in Lyme Disease Testing, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2023
Table 64. Head Office of Key Lyme Disease Testing Players
Table 65. Lyme Disease Testing Market: Company Product Type Footprint
Table 66. Lyme Disease Testing Market: Company Product Application Footprint
Table 67. Lyme Disease Testing New Market Entrants and Barriers to Market Entry
Table 68. Lyme Disease Testing Mergers, Acquisition, Agreements, and Collaborations
Table 69. Global Lyme Disease Testing Consumption Value (USD Million) by Type (2019-2024)
Table 70. Global Lyme Disease Testing Consumption Value Share by Type (2019-2024)
Table 71. Global Lyme Disease Testing Consumption Value Forecast by Type (2025-2030)
Table 72. Global Lyme Disease Testing Consumption Value by Application (2019-2024)
Table 73. Global Lyme Disease Testing Consumption Value Forecast by Application (2025-2030)
Table 74. North America Lyme Disease Testing Consumption Value by Type (2019-2024) & (USD Million)
Table 75. North America Lyme Disease Testing Consumption Value by Type (2025-2030) & (USD Million)
Table 76. North America Lyme Disease Testing Consumption Value by Application (2019-2024) & (USD Million)
Table 77. North America Lyme Disease Testing Consumption Value by Application (2025-2030) & (USD Million)
Table 78. North America Lyme Disease Testing Consumption Value by Country (2019-2024) & (USD Million)
Table 79. North America Lyme Disease Testing Consumption Value by Country (2025-2030) & (USD Million)
Table 80. Europe Lyme Disease Testing Consumption Value by Type (2019-2024) & (USD Million)
Table 81. Europe Lyme Disease Testing Consumption Value by Type (2025-2030) & (USD Million)
Table 82. Europe Lyme Disease Testing Consumption Value by Application (2019-2024) & (USD Million)
Table 83. Europe Lyme Disease Testing Consumption Value by Application (2025-2030) & (USD Million)
Table 84. Europe Lyme Disease Testing Consumption Value by Country (2019-2024) & (USD Million)
Table 85. Europe Lyme Disease Testing Consumption Value by Country (2025-2030) & (USD Million)
Table 86. Asia-Pacific Lyme Disease Testing Consumption Value by Type (2019-2024) & (USD Million)
Table 87. Asia-Pacific Lyme Disease Testing Consumption Value by Type (2025-2030) & (USD Million)
Table 88. Asia-Pacific Lyme Disease Testing Consumption Value by Application (2019-2024) & (USD Million)
Table 89. Asia-Pacific Lyme Disease Testing Consumption Value by Application (2025-2030) & (USD Million)
Table 90. Asia-Pacific Lyme Disease Testing Consumption Value by Region (2019-2024) & (USD Million)
Table 91. Asia-Pacific Lyme Disease Testing Consumption Value by Region (2025-2030) & (USD Million)
Table 92. South America Lyme Disease Testing Consumption Value by Type (2019-2024) & (USD Million)
Table 93. South America Lyme Disease Testing Consumption Value by Type (2025-2030) & (USD Million)
Table 94. South America Lyme Disease Testing Consumption Value by Application (2019-2024) & (USD Million)
Table 95. South America Lyme Disease Testing Consumption Value by Application (2025-2030) & (USD Million)
Table 96. South America Lyme Disease Testing Consumption Value by Country (2019-2024) & (USD Million)
Table 97. South America Lyme Disease Testing Consumption Value by Country (2025-2030) & (USD Million)
Table 98. Middle East & Africa Lyme Disease Testing Consumption Value by Type (2019-2024) & (USD Million)
Table 99. Middle East & Africa Lyme Disease Testing Consumption Value by Type (2025-2030) & (USD Million)
Table 100. Middle East & Africa Lyme Disease Testing Consumption Value by Application (2019-2024) & (USD Million)
Table 101. Middle East & Africa Lyme Disease Testing Consumption Value by Application (2025-2030) & (USD Million)
Table 102. Middle East & Africa Lyme Disease Testing Consumption Value by Country (2019-2024) & (USD Million)
Table 103. Middle East & Africa Lyme Disease Testing Consumption Value by Country (2025-2030) & (USD Million)
Table 104. Lyme Disease Testing Raw Material
Table 105. Key Suppliers of Lyme Disease Testing Raw Materials
Table 1. Global Lyme Disease Testing Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Lyme Disease Testing Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Global Lyme Disease Testing Consumption Value by Region (2019-2024) & (USD Million)
Table 4. Global Lyme Disease Testing Consumption Value by Region (2025-2030) & (USD Million)
Table 5. Quidel Corporation Company Information, Head Office, and Major Competitors
Table 6. Quidel Corporation Major Business
Table 7. Quidel Corporation Lyme Disease Testing Product and Solutions
Table 8. Quidel Corporation Lyme Disease Testing Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 9. Quidel Corporation Recent Developments and Future Plans
Table 10. Roche Holding AG Company Information, Head Office, and Major Competitors
Table 11. Roche Holding AG Major Business
Table 12. Roche Holding AG Lyme Disease Testing Product and Solutions
Table 13. Roche Holding AG Lyme Disease Testing Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 14. Roche Holding AG Recent Developments and Future Plans
Table 15. Fujirebio(H.U. Group Holdings) Company Information, Head Office, and Major Competitors
Table 16. Fujirebio(H.U. Group Holdings) Major Business
Table 17. Fujirebio(H.U. Group Holdings) Lyme Disease Testing Product and Solutions
Table 18. Fujirebio(H.U. Group Holdings) Lyme Disease Testing Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 19. Fujirebio(H.U. Group Holdings) Recent Developments and Future Plans
Table 20. ZEUS Scientific Company Information, Head Office, and Major Competitors
Table 21. ZEUS Scientific Major Business
Table 22. ZEUS Scientific Lyme Disease Testing Product and Solutions
Table 23. ZEUS Scientific Lyme Disease Testing Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 24. ZEUS Scientific Recent Developments and Future Plans
Table 25. IGeneX Company Information, Head Office, and Major Competitors
Table 26. IGeneX Major Business
Table 27. IGeneX Lyme Disease Testing Product and Solutions
Table 28. IGeneX Lyme Disease Testing Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 29. IGeneX Recent Developments and Future Plans
Table 30. Thermo Fisher Scientific Company Information, Head Office, and Major Competitors
Table 31. Thermo Fisher Scientific Major Business
Table 32. Thermo Fisher Scientific Lyme Disease Testing Product and Solutions
Table 33. Thermo Fisher Scientific Lyme Disease Testing Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 34. Thermo Fisher Scientific Recent Developments and Future Plans
Table 35. Everlywell Company Information, Head Office, and Major Competitors
Table 36. Everlywell Major Business
Table 37. Everlywell Lyme Disease Testing Product and Solutions
Table 38. Everlywell Lyme Disease Testing Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 39. Everlywell Recent Developments and Future Plans
Table 40. Oxford Immunotec Global PLC(PerkinElmer) Company Information, Head Office, and Major Competitors
Table 41. Oxford Immunotec Global PLC(PerkinElmer) Major Business
Table 42. Oxford Immunotec Global PLC(PerkinElmer) Lyme Disease Testing Product and Solutions
Table 43. Oxford Immunotec Global PLC(PerkinElmer) Lyme Disease Testing Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 44. Oxford Immunotec Global PLC(PerkinElmer) Recent Developments and Future Plans
Table 45. BioMerieux Company Information, Head Office, and Major Competitors
Table 46. BioMerieux Major Business
Table 47. BioMerieux Lyme Disease Testing Product and Solutions
Table 48. BioMerieux Lyme Disease Testing Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 49. BioMerieux Recent Developments and Future Plans
Table 50. Bio-Rad Laboratories Company Information, Head Office, and Major Competitors
Table 51. Bio-Rad Laboratories Major Business
Table 52. Bio-Rad Laboratories Lyme Disease Testing Product and Solutions
Table 53. Bio-Rad Laboratories Lyme Disease Testing Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 54. Bio-Rad Laboratories Recent Developments and Future Plans
Table 55. T2 Biosystems Company Information, Head Office, and Major Competitors
Table 56. T2 Biosystems Major Business
Table 57. T2 Biosystems Lyme Disease Testing Product and Solutions
Table 58. T2 Biosystems Lyme Disease Testing Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 59. T2 Biosystems Recent Developments and Future Plans
Table 60. Global Lyme Disease Testing Revenue (USD Million) by Players (2019-2024)
Table 61. Global Lyme Disease Testing Revenue Share by Players (2019-2024)
Table 62. Breakdown of Lyme Disease Testing by Company Type (Tier 1, Tier 2, and Tier 3)
Table 63. Market Position of Players in Lyme Disease Testing, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2023
Table 64. Head Office of Key Lyme Disease Testing Players
Table 65. Lyme Disease Testing Market: Company Product Type Footprint
Table 66. Lyme Disease Testing Market: Company Product Application Footprint
Table 67. Lyme Disease Testing New Market Entrants and Barriers to Market Entry
Table 68. Lyme Disease Testing Mergers, Acquisition, Agreements, and Collaborations
Table 69. Global Lyme Disease Testing Consumption Value (USD Million) by Type (2019-2024)
Table 70. Global Lyme Disease Testing Consumption Value Share by Type (2019-2024)
Table 71. Global Lyme Disease Testing Consumption Value Forecast by Type (2025-2030)
Table 72. Global Lyme Disease Testing Consumption Value by Application (2019-2024)
Table 73. Global Lyme Disease Testing Consumption Value Forecast by Application (2025-2030)
Table 74. North America Lyme Disease Testing Consumption Value by Type (2019-2024) & (USD Million)
Table 75. North America Lyme Disease Testing Consumption Value by Type (2025-2030) & (USD Million)
Table 76. North America Lyme Disease Testing Consumption Value by Application (2019-2024) & (USD Million)
Table 77. North America Lyme Disease Testing Consumption Value by Application (2025-2030) & (USD Million)
Table 78. North America Lyme Disease Testing Consumption Value by Country (2019-2024) & (USD Million)
Table 79. North America Lyme Disease Testing Consumption Value by Country (2025-2030) & (USD Million)
Table 80. Europe Lyme Disease Testing Consumption Value by Type (2019-2024) & (USD Million)
Table 81. Europe Lyme Disease Testing Consumption Value by Type (2025-2030) & (USD Million)
Table 82. Europe Lyme Disease Testing Consumption Value by Application (2019-2024) & (USD Million)
Table 83. Europe Lyme Disease Testing Consumption Value by Application (2025-2030) & (USD Million)
Table 84. Europe Lyme Disease Testing Consumption Value by Country (2019-2024) & (USD Million)
Table 85. Europe Lyme Disease Testing Consumption Value by Country (2025-2030) & (USD Million)
Table 86. Asia-Pacific Lyme Disease Testing Consumption Value by Type (2019-2024) & (USD Million)
Table 87. Asia-Pacific Lyme Disease Testing Consumption Value by Type (2025-2030) & (USD Million)
Table 88. Asia-Pacific Lyme Disease Testing Consumption Value by Application (2019-2024) & (USD Million)
Table 89. Asia-Pacific Lyme Disease Testing Consumption Value by Application (2025-2030) & (USD Million)
Table 90. Asia-Pacific Lyme Disease Testing Consumption Value by Region (2019-2024) & (USD Million)
Table 91. Asia-Pacific Lyme Disease Testing Consumption Value by Region (2025-2030) & (USD Million)
Table 92. South America Lyme Disease Testing Consumption Value by Type (2019-2024) & (USD Million)
Table 93. South America Lyme Disease Testing Consumption Value by Type (2025-2030) & (USD Million)
Table 94. South America Lyme Disease Testing Consumption Value by Application (2019-2024) & (USD Million)
Table 95. South America Lyme Disease Testing Consumption Value by Application (2025-2030) & (USD Million)
Table 96. South America Lyme Disease Testing Consumption Value by Country (2019-2024) & (USD Million)
Table 97. South America Lyme Disease Testing Consumption Value by Country (2025-2030) & (USD Million)
Table 98. Middle East & Africa Lyme Disease Testing Consumption Value by Type (2019-2024) & (USD Million)
Table 99. Middle East & Africa Lyme Disease Testing Consumption Value by Type (2025-2030) & (USD Million)
Table 100. Middle East & Africa Lyme Disease Testing Consumption Value by Application (2019-2024) & (USD Million)
Table 101. Middle East & Africa Lyme Disease Testing Consumption Value by Application (2025-2030) & (USD Million)
Table 102. Middle East & Africa Lyme Disease Testing Consumption Value by Country (2019-2024) & (USD Million)
Table 103. Middle East & Africa Lyme Disease Testing Consumption Value by Country (2025-2030) & (USD Million)
Table 104. Lyme Disease Testing Raw Material
Table 105. Key Suppliers of Lyme Disease Testing Raw Materials
LIST OF FIGURES
Figure 1. Lyme Disease Testing Picture
Figure 2. Global Lyme Disease Testing Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Lyme Disease Testing Consumption Value Market Share by Type in 2023
Figure 4. ELISA
Figure 5. Western Blotting
Figure 6. PCR
Figure 7. Others
Figure 8. Global Lyme Disease Testing Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 9. Lyme Disease Testing Consumption Value Market Share by Application in 2023
Figure 10. Hospital and Testing Agency Picture
Figure 11. Personal Picture
Figure 12. Global Lyme Disease Testing Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 13. Global Lyme Disease Testing Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 14. Global Market Lyme Disease Testing Consumption Value (USD Million) Comparison by Region (2019 & 2023 & 2030)
Figure 15. Global Lyme Disease Testing Consumption Value Market Share by Region (2019-2030)
Figure 16. Global Lyme Disease Testing Consumption Value Market Share by Region in 2023
Figure 17. North America Lyme Disease Testing Consumption Value (2019-2030) & (USD Million)
Figure 18. Europe Lyme Disease Testing Consumption Value (2019-2030) & (USD Million)
Figure 19. Asia-Pacific Lyme Disease Testing Consumption Value (2019-2030) & (USD Million)
Figure 20. South America Lyme Disease Testing Consumption Value (2019-2030) & (USD Million)
Figure 21. Middle East and Africa Lyme Disease Testing Consumption Value (2019-2030) & (USD Million)
Figure 22. Global Lyme Disease Testing Revenue Share by Players in 2023
Figure 23. Lyme Disease Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2023
Figure 24. Global Top 3 Players Lyme Disease Testing Market Share in 2023
Figure 25. Global Top 6 Players Lyme Disease Testing Market Share in 2023
Figure 26. Global Lyme Disease Testing Consumption Value Share by Type (2019-2024)
Figure 27. Global Lyme Disease Testing Market Share Forecast by Type (2025-2030)
Figure 28. Global Lyme Disease Testing Consumption Value Share by Application (2019-2024)
Figure 29. Global Lyme Disease Testing Market Share Forecast by Application (2025-2030)
Figure 30. North America Lyme Disease Testing Consumption Value Market Share by Type (2019-2030)
Figure 31. North America Lyme Disease Testing Consumption Value Market Share by Application (2019-2030)
Figure 32. North America Lyme Disease Testing Consumption Value Market Share by Country (2019-2030)
Figure 33. United States Lyme Disease Testing Consumption Value (2019-2030) & (USD Million)
Figure 34. Canada Lyme Disease Testing Consumption Value (2019-2030) & (USD Million)
Figure 35. Mexico Lyme Disease Testing Consumption Value (2019-2030) & (USD Million)
Figure 36. Europe Lyme Disease Testing Consumption Value Market Share by Type (2019-2030)
Figure 37. Europe Lyme Disease Testing Consumption Value Market Share by Application (2019-2030)
Figure 38. Europe Lyme Disease Testing Consumption Value Market Share by Country (2019-2030)
Figure 39. Germany Lyme Disease Testing Consumption Value (2019-2030) & (USD Million)
Figure 40. France Lyme Disease Testing Consumption Value (2019-2030) & (USD Million)
Figure 41. United Kingdom Lyme Disease Testing Consumption Value (2019-2030) & (USD Million)
Figure 42. Russia Lyme Disease Testing Consumption Value (2019-2030) & (USD Million)
Figure 43. Italy Lyme Disease Testing Consumption Value (2019-2030) & (USD Million)
Figure 44. Asia-Pacific Lyme Disease Testing Consumption Value Market Share by Type (2019-2030)
Figure 45. Asia-Pacific Lyme Disease Testing Consumption Value Market Share by Application (2019-2030)
Figure 46. Asia-Pacific Lyme Disease Testing Consumption Value Market Share by Region (2019-2030)
Figure 47. China Lyme Disease Testing Consumption Value (2019-2030) & (USD Million)
Figure 48. Japan Lyme Disease Testing Consumption Value (2019-2030) & (USD Million)
Figure 49. South Korea Lyme Disease Testing Consumption Value (2019-2030) & (USD Million)
Figure 50. India Lyme Disease Testing Consumption Value (2019-2030) & (USD Million)
Figure 51. Southeast Asia Lyme Disease Testing Consumption Value (2019-2030) & (USD Million)
Figure 52. Australia Lyme Disease Testing Consumption Value (2019-2030) & (USD Million)
Figure 53. South America Lyme Disease Testing Consumption Value Market Share by Type (2019-2030)
Figure 54. South America Lyme Disease Testing Consumption Value Market Share by Application (2019-2030)
Figure 55. South America Lyme Disease Testing Consumption Value Market Share by Country (2019-2030)
Figure 56. Brazil Lyme Disease Testing Consumption Value (2019-2030) & (USD Million)
Figure 57. Argentina Lyme Disease Testing Consumption Value (2019-2030) & (USD Million)
Figure 58. Middle East and Africa Lyme Disease Testing Consumption Value Market Share by Type (2019-2030)
Figure 59. Middle East and Africa Lyme Disease Testing Consumption Value Market Share by Application (2019-2030)
Figure 60. Middle East and Africa Lyme Disease Testing Consumption Value Market Share by Country (2019-2030)
Figure 61. Turkey Lyme Disease Testing Consumption Value (2019-2030) & (USD Million)
Figure 62. Saudi Arabia Lyme Disease Testing Consumption Value (2019-2030) & (USD Million)
Figure 63. UAE Lyme Disease Testing Consumption Value (2019-2030) & (USD Million)
Figure 64. Lyme Disease Testing Market Drivers
Figure 65. Lyme Disease Testing Market Restraints
Figure 66. Lyme Disease Testing Market Trends
Figure 67. Porters Five Forces Analysis
Figure 68. Manufacturing Cost Structure Analysis of Lyme Disease Testing in 2023
Figure 69. Manufacturing Process Analysis of Lyme Disease Testing
Figure 70. Lyme Disease Testing Industrial Chain
Figure 71. Methodology
Figure 72. Research Process and Data Source
Figure 1. Lyme Disease Testing Picture
Figure 2. Global Lyme Disease Testing Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Lyme Disease Testing Consumption Value Market Share by Type in 2023
Figure 4. ELISA
Figure 5. Western Blotting
Figure 6. PCR
Figure 7. Others
Figure 8. Global Lyme Disease Testing Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 9. Lyme Disease Testing Consumption Value Market Share by Application in 2023
Figure 10. Hospital and Testing Agency Picture
Figure 11. Personal Picture
Figure 12. Global Lyme Disease Testing Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 13. Global Lyme Disease Testing Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 14. Global Market Lyme Disease Testing Consumption Value (USD Million) Comparison by Region (2019 & 2023 & 2030)
Figure 15. Global Lyme Disease Testing Consumption Value Market Share by Region (2019-2030)
Figure 16. Global Lyme Disease Testing Consumption Value Market Share by Region in 2023
Figure 17. North America Lyme Disease Testing Consumption Value (2019-2030) & (USD Million)
Figure 18. Europe Lyme Disease Testing Consumption Value (2019-2030) & (USD Million)
Figure 19. Asia-Pacific Lyme Disease Testing Consumption Value (2019-2030) & (USD Million)
Figure 20. South America Lyme Disease Testing Consumption Value (2019-2030) & (USD Million)
Figure 21. Middle East and Africa Lyme Disease Testing Consumption Value (2019-2030) & (USD Million)
Figure 22. Global Lyme Disease Testing Revenue Share by Players in 2023
Figure 23. Lyme Disease Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2023
Figure 24. Global Top 3 Players Lyme Disease Testing Market Share in 2023
Figure 25. Global Top 6 Players Lyme Disease Testing Market Share in 2023
Figure 26. Global Lyme Disease Testing Consumption Value Share by Type (2019-2024)
Figure 27. Global Lyme Disease Testing Market Share Forecast by Type (2025-2030)
Figure 28. Global Lyme Disease Testing Consumption Value Share by Application (2019-2024)
Figure 29. Global Lyme Disease Testing Market Share Forecast by Application (2025-2030)
Figure 30. North America Lyme Disease Testing Consumption Value Market Share by Type (2019-2030)
Figure 31. North America Lyme Disease Testing Consumption Value Market Share by Application (2019-2030)
Figure 32. North America Lyme Disease Testing Consumption Value Market Share by Country (2019-2030)
Figure 33. United States Lyme Disease Testing Consumption Value (2019-2030) & (USD Million)
Figure 34. Canada Lyme Disease Testing Consumption Value (2019-2030) & (USD Million)
Figure 35. Mexico Lyme Disease Testing Consumption Value (2019-2030) & (USD Million)
Figure 36. Europe Lyme Disease Testing Consumption Value Market Share by Type (2019-2030)
Figure 37. Europe Lyme Disease Testing Consumption Value Market Share by Application (2019-2030)
Figure 38. Europe Lyme Disease Testing Consumption Value Market Share by Country (2019-2030)
Figure 39. Germany Lyme Disease Testing Consumption Value (2019-2030) & (USD Million)
Figure 40. France Lyme Disease Testing Consumption Value (2019-2030) & (USD Million)
Figure 41. United Kingdom Lyme Disease Testing Consumption Value (2019-2030) & (USD Million)
Figure 42. Russia Lyme Disease Testing Consumption Value (2019-2030) & (USD Million)
Figure 43. Italy Lyme Disease Testing Consumption Value (2019-2030) & (USD Million)
Figure 44. Asia-Pacific Lyme Disease Testing Consumption Value Market Share by Type (2019-2030)
Figure 45. Asia-Pacific Lyme Disease Testing Consumption Value Market Share by Application (2019-2030)
Figure 46. Asia-Pacific Lyme Disease Testing Consumption Value Market Share by Region (2019-2030)
Figure 47. China Lyme Disease Testing Consumption Value (2019-2030) & (USD Million)
Figure 48. Japan Lyme Disease Testing Consumption Value (2019-2030) & (USD Million)
Figure 49. South Korea Lyme Disease Testing Consumption Value (2019-2030) & (USD Million)
Figure 50. India Lyme Disease Testing Consumption Value (2019-2030) & (USD Million)
Figure 51. Southeast Asia Lyme Disease Testing Consumption Value (2019-2030) & (USD Million)
Figure 52. Australia Lyme Disease Testing Consumption Value (2019-2030) & (USD Million)
Figure 53. South America Lyme Disease Testing Consumption Value Market Share by Type (2019-2030)
Figure 54. South America Lyme Disease Testing Consumption Value Market Share by Application (2019-2030)
Figure 55. South America Lyme Disease Testing Consumption Value Market Share by Country (2019-2030)
Figure 56. Brazil Lyme Disease Testing Consumption Value (2019-2030) & (USD Million)
Figure 57. Argentina Lyme Disease Testing Consumption Value (2019-2030) & (USD Million)
Figure 58. Middle East and Africa Lyme Disease Testing Consumption Value Market Share by Type (2019-2030)
Figure 59. Middle East and Africa Lyme Disease Testing Consumption Value Market Share by Application (2019-2030)
Figure 60. Middle East and Africa Lyme Disease Testing Consumption Value Market Share by Country (2019-2030)
Figure 61. Turkey Lyme Disease Testing Consumption Value (2019-2030) & (USD Million)
Figure 62. Saudi Arabia Lyme Disease Testing Consumption Value (2019-2030) & (USD Million)
Figure 63. UAE Lyme Disease Testing Consumption Value (2019-2030) & (USD Million)
Figure 64. Lyme Disease Testing Market Drivers
Figure 65. Lyme Disease Testing Market Restraints
Figure 66. Lyme Disease Testing Market Trends
Figure 67. Porters Five Forces Analysis
Figure 68. Manufacturing Cost Structure Analysis of Lyme Disease Testing in 2023
Figure 69. Manufacturing Process Analysis of Lyme Disease Testing
Figure 70. Lyme Disease Testing Industrial Chain
Figure 71. Methodology
Figure 72. Research Process and Data Source
